Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT.

Livio PaganoAlessio Maria Edoardo MaraglinoLuana FianchiMarianna CriscuoloElena RossiTommaso ZaPatrizia ChiusoloMatteo BonanniGiulia DragonettiAndrea BacigalupoSimona SicaValerio De Stefano

Published in: Annals of hematology (2019)

Keyphrases

cell therapy
high dose
low dose
bone marrow
single cell
acute myeloid leukemia
multiple myeloma
stem cells